MedTrace Logo

Palliative Oxygen for the Relief of Breathlessness

NCT00327873 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2009-12-14

No results posted yet for this study

Summary

The main goal of this study is to establish the effectiveness of palliative oxygen in the context within which it is usually provided--relief of the sensation of breathlessness and improvement in quality of life for people with maximally-treated life-limiting illness.

Conditions

Interventions

OTHER

Oxygen

2L/min for 15 hours or greater per day via concentrator and nasal cannulae for 7 days

OTHER

Medical Air

2L/min for 15 hours or greater per day via concentrator and nasal cannulae for 7 days

Sponsors & Collaborators

  • Doris Duke Charitable Foundation

    collaborator OTHER

  • Cancer Council Tasmania

    collaborator OTHER

  • Duke Institute on Care at the End of Life, USA

    collaborator UNKNOWN

  • Flinders Medical Research Institute Small Research Grants Scheme, Australia

    collaborator UNKNOWN

  • National Health and Medical Research Council, Australia

    lead OTHER

Principal Investigators

  • Amy Abernethy, MD · Duke University

  • David Curow, BMed,FRACP,MPH · Flinders University, Australia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • United States
  • Australia
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00327873 on ClinicalTrials.gov